A recent publication suggested that TFEB de-phosphorylation and nuclear translocation in a model of Niemann-Pick type C disease (NPC) upon c-Abl inhibition with dasatinib (Contreras et al., 2020). The gene discussed is ABL1; the disease is Niemann-Pick disease type C.